Monthly Global Upstream Review March 2017 MediPoint Enteral Stents Europe Forecast and Marke

MediPoint Enteral Stents Europe Forecast and Market Analysis
ReportsWeb.com published “MediPoint Enteral Stents Market” from its database. The report
covers the market landscape and its growth prospects over the coming years. The report also
includes a discussion of the key vendors operating in this market.
Enteral stents are a palliative treatment option for constrictions caused primarily by various
cancers. The primary cancers which cause constrictions requiring the use of enteral stents are
esophageal cancer, gastric cancer, pancreatic cancer, and colorectal cancer. There are three
primary enteral stents; the covered enteral stent, the partially covered enteral stents, and the
non-covered enteral stent. The market is led by three key players. The market will continue to
grow as cancer prevalence increases and patients become more familiar with enteral stenting
as a treatment option. This report examines the enteral stents market in 21 major European
markets: Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Germany,
Hungary, Ireland, Italy, Netherlands, Norway, Poland, Portugal, Russia, Spain, Sweden,
Switzerland, Turkey and the UK.
This report provides insight into the adoption trends, market dynamics, competitive landscape,
marketed products, current players, as well as market outlooks in the European market.
For more information about this report: http://www.reportsweb.com/medipoint-enteral-
stents-europe-forecast-and-market-analysis
Table of Content:
Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Executive Summary 5
2.1 Overview 5
2.2 Market Dynamics 6